| Product NDC: | 52565-013 |
| Proprietary Name: | Fluocinolone Acetonide |
| Non Proprietary Name: | Fluocinolone Acetonide |
| Active Ingredient(s): | .25 mg/g & nbsp; Fluocinolone Acetonide |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52565-013 |
| Labeler Name: | IGI Labs, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA013960 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20121227 |
| Package NDC: | 52565-013-15 |
| Package Description: | 1 TUBE in 1 CARTON (52565-013-15) > 15 g in 1 TUBE |
| NDC Code | 52565-013-15 |
| Proprietary Name | Fluocinolone Acetonide |
| Package Description | 1 TUBE in 1 CARTON (52565-013-15) > 15 g in 1 TUBE |
| Product NDC | 52565-013 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fluocinolone Acetonide |
| Dosage Form Name | OINTMENT |
| Route Name | TOPICAL |
| Start Marketing Date | 20121227 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | IGI Labs, Inc. |
| Substance Name | FLUOCINOLONE ACETONIDE |
| Strength Number | .25 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |